Medgenics (MDGN) Tops Q3 EPS by 1c

November 3, 2016 9:24 AM EDT
Get Alerts MDGN Hot Sheet
Trade MDGN Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Medgenics (NASDAQ: MDGN) reported Q3 EPS of ($0.29), $0.01 better than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Medgenics (MDGN) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment